
Key Point:
British American Tobacco's investment plan in Spain is limited: BAT is considering establishing a new tobacco product factory in Barcelona, Spain, but is facing obstacles in the regulatory environment.
Regulatory policies questioned: Spanish Health Department intends to ban nicotine pouches and flavored e-cigarettes, BAT claims it will severely impact the legal market and fuel the black market.
Market layout affected: Spain's investment advantage is lost due to policy uncertainty compared to Croatia and the Czech Republic.
Clear business transformation goals: BAT plans to have 50% of its revenue come from new tobacco products by 2030.
According to Expansion on April 15th, British American Tobacco (BAT) is planning to invest in the construction of a new tobacco product factory in Spain, with an expected investment of 500 million euros.
Barcelona is considered a potential investment location due to its excellent geographical location and convenient transportation, making it a prime choice for BAT. However, the strict regulatory policies of the Spanish government on tobacco alternatives, particularly the restrictions on e-cigarette flavors and nicotine pouch nicotine concentrations, are causing uncertainty for BAT's investment plans. Other locations BAT is considering are Croatia and the Czech Republic.
BAT's General Manager for Spain and Portugal, Javier Álvarez Ballespín, has expressed concerns about the current regulatory policies of the Spanish government, stating that they are making the investment environment complex. Specifically, he highlighted the government's proposed "Real Decreto de Sanidad," which would limit the nicotine content in pouches to 0.99 milligrams, significantly lower than the common 4 milligrams in the market, making the product nearly unsellable. Additionally, restrictions on e-cigarette flavors are expected to impact consumer choice, leading to potential market exits and an increase in illicit trade, according to BAT.
According to Alvarez, the acceptance of new tobacco products in the Spanish market is gradually increasing, but there are still certain obstacles to growth. New tobacco products account for 17% of BAT's total revenue globally, but in Spain, this proportion reaches 25% and is expected to reach 50% by 2030. The executive warned that "if these categories are effectively banned, BAT's future in Spain will become complicated.
BAT's global strategy is to continue investing in multiple new tobacco product lines, including e-cigarettes (Vuse), heated tobacco (Glo), and nicotine pouches (Velo). Alvarez emphasized that although BAT's diversified portfolio increases operational complexity, it also provides a competitive advantage.
BAT plans to further expand the market for new tobacco products, especially in the areas of heated tobacco and nicotine pouches, with hopes of doubling or even tripling this revenue by 2030. However, Alvarez warned that if current policies are implemented, BAT will face significant challenges in Spain.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com